37. Injectable Vs. Sublingual Buprenorphine

Addiction Medicine Journal Club

内容由Sonya Del Tredici and John Keenan, Sonya Del Tredici, and John Keenan提供。所有播客内容（包括剧集、图形和播客描述）均由 Sonya Del Tredici and John Keenan, Sonya Del Tredici, and John Keenan 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

9M ago 46:46

MP3•单集首页

37. Injectable Vs. Sublingual Buprenorphine

In episode 37 we discuss an article comparing injectable and sublingual buprenorphine.

Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial. Marsden, John et al. eClinicalMedicine, Volume 66, 102311

We also discuss new data on the teratogenicity of fentanyl, and a new genetic test to identify the risk for opioid use disorder.

Genetics on Medicine Open: A novel syndrome associated with prenatal fentanyl exposure

FDA: FDA Approves First Test to Help Identify Elevated Risk of Developing Opioid Use Disorder

----------

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, please visit MI CARES.

----------

Episode 37 Credits:

Original theme music: composed and performed by Benjamin Kennedy
Audio production: Erin McCue
Executive Producer: Dr. Patrick Beeman
A podcast from Ars Longa Media

----------

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

Email: addictionmedicinejournalclub@gmail.com
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
Instagram: @AddictionMedJC
Threads: @AddictionMedJC
Twitter/X: @AddictionMedJC
YouTube: addictionmedicinejournalclub

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

58集单集